Health
Pfizer, BioNTech Seek US Emergency OK for COVID-19 Vaccine in Adolescents – Voice of America
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15. The vaccine is currently…
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15.
The vaccine is currently authorized for emergency use in the United States for people age 16 and older. The companies said Friday that they requested an expansion of the authorization from the U.S. Food and Drug Administration (FDA) to include the younger age group.
In March, the drugmakers said the vaccine was found to be safe and effective and had produced…
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Business6 hours agoFord CEO makes stunning prediction about artificial intelligence